Skip to main content

Neuroscience

Neuroscience Research Institute

Clinical Trials

Showing 10-18 out of 23 results.
NCT05399888

Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Icon for trial | 247AD201 Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer&rsqu

This study is currently enrolling.

Alzheimer’s Disease (AD): The purpose of this study is to look at whether BIIB080 (the study drug) can help people with Alzheimer’s Disease (AD), how safe it is, and how the body handles taking it (known as tolerability). Parti ...

NCT05526391

Takeda Development Center Americas, Inc. / “A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy”

Icon for trial | TAK-341-2001 Takeda Development Center Americas, Inc. / “A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Mul

This study is currently enrolling.

Multiple System Atrophy: The goals of this study are to find out the following: How effective is TAK-341 in treating people with MSA. Assess what TAK-341 does to the body (pharmacokinetics [PK]) and measure the amount of TAK-34 ...